Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

BACKGROUND/AIMS: We compared the efficacies of entecavir (ETV) plus tenofovir (TDF) and ETV plus adefovir (ADV) in chronic hepatitis B (CHB) patients with genotypic resistance to lamivudine (LAM) who showed a suboptimal response to LAM and ADV combination therapy. METHODS: We reviewed 63 CHB patient...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Mol Hepatol
Autors principals: Park, Jung Gil, Park, Soo Young
Format: Artigo
Idioma:Inglês
Publicat: The Korean Association for the Study of the Liver 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4612285/
https://ncbi.nlm.nih.gov/pubmed/26523269
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.3.242
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars